BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

8 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Integrated Synthesis and Testing of Substituted Xanthine Based DPP4 Inhibitors: Application to Drug Discovery.EBI
Sanofi-Aventis
Discovery of the first non-ATP competitive IGF-1R kinase inhibitors: advantages in comparison with competitive inhibitors.EBI
Sanofi-Aventis
Allosteric and ATP-competitive kinase inhibitors of mTOR for cancer treatment.EBI
Sanofi-Aventis
Design of potent and selective GSK3beta inhibitors with acceptable safety profile and pharmacokinetics.EBI
Sanofi-Aventis
Fragment screening of inhibitors for MIF tautomerase reveals a cryptic surface binding site.EBI
Sanofi-Aventis
Rational design of potent GSK3beta inhibitors with selectivity for Cdk1 and Cdk2.EBI
Sanofi-Aventis
Discovery of novel inhibitors for DHODH via virtual screening and X-ray crystallographic structures.EBI
Sanofi-Aventis
Structural analysis of isoform-specific inhibitors targeting the tetrahydrobiopterin binding site of human nitric oxide synthases.EBI
Sanofi-Aventis